![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI/S) | LSE:TYR | London | Ordinary Share | COM SHS USD0.001 (DI / REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.95 | 2.70 | 3.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTYR TIDMTYRU
RNS Number : 5439X
TyraTech, Inc.
14 January 2014
14 January 2014
TyraTech Inc
("TyraTech" or the "Company")
Vamousse(TM) head lice treatment coming to Walmart stores in the USA
TyraTech, Inc. (AIM: TYR and TYRU) a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce its head lice treatment product, Vamousse(TM), will come to Walmart stores in the USA from the end of March 2014.
The USA market for head lice control products is estimated by TyraTech as being worth approximately $150 million per annum. Given the superior efficacy and safety of Vamousse(TM), TyraTech believes it is in a position to achieve strong penetration of this market for its breakthrough head lice product, reinforcing their confidence in meeting market expectations for 2014 revenues.
Bruno Jactel, Chief Executive Officer, said: "I am delighted to report that TyraTech's breakthrough technology and innovative products are capturing the attention of major retailers. This is our most important milestone to date as it will significantly raise the profile of TyraTech's brands in the US, helping us further expand our market penetration and market share. In addition, the fact that Vamousse(TM) will come to Walmart stores reinforces our strategy of establishing our own brands within the market place.
This is an exciting development for TyraTech and we look forward to the future with great confidence."
Further information on Vamousse(TM) is available on the Company's website at: http://www.tyratech.com/content/company-products/head-lice.asp
For further information please contact:
TyraTech Inc. Alan Reade, Non-Executive Chairman Tel: +44 7841978709 Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4340 SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady Tel: +44203 368 3551 Allenby Capital Limited , Joint Broker Chris Crawford Tel: 44 20 3328 5656 Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Tel: +44 20 7933 8792 Paul Cornelius (Investor Relations) Tel: +44 20 7933 8794
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGGUWCGUPCGQW
1 Year Tyratech Chart |
1 Month Tyratech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions